CSPC Pharmaceutical Group Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From CSPC Pharmaceutical Group Limited
Aevi needs to raise funds first, but hopes to develop MEDI2338 for adult-onset Still’s disease. Also, Alnylam plans to leverage Ironwood’s GI expertise for givosiran in acute hepatic porphyria and Ultragenyx snags option to buy GeneTx.
Deals among domestic Chinese biotechs are growing fast, reflecting a need to huddle up amid tightening scrutiny over biotech deal-making and an unusually competitive immuno-oncology market.
Tris acquires Pfizer subsidiary Nextwave, which developed pair of ADHD drugs using Tris delivery technology. Lilly gets oral CGRP candidate from Chugai, while Dova signs US co-promotion partner for Doptelet.
Bellwethers tell you something, but to gauge the health of the pharmaceutical industry, you really need the Scrip 100. For FY 2016, it looks like drug sales are up again and profits are down. But is this what's actually going on?
- Medical Devices
- Research, Analytical Equipment & Supplies
- Generic Drugs
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Large Molecule
- Other Names / Subsidiaries
- NovaRock Biotherapeutics, Shijiazhuang Pharma Group
- China Shijiazhuang Pharmaceutical Group Co Ltd
- Hong Kong Tainuo Pharma Ltd
- Jiangsu Tainuo Pharmaceutical Co Ltd
- CSPC Pharmaceutical Group Co., Ltd.